Join the Biofuels Brazil Forum 2024!
October 16, 2024
Biofuels Brazil Forum 2024 Join the Biofuels Brazil Forum 2024! New York, October 15, 2024 – We are pleased to announce that PRISM Mediawire will
Biofuels Brazil Forum 2024 Join the Biofuels Brazil Forum 2024! New York, October 15, 2024 – We are pleased to announce that PRISM Mediawire will
IRVINE, Calif., Oct. 16, 2024 – PRISM MediaWire – Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announced today that CEO Josh Riggs is scheduled to present
PITTSBURGH, PA, October 15, 2024 – PRISM MediaWire – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company focused on developing therapies for serious diseases
KLTO strengthens team with industry veteran and is poised to accelerate the development of its therapeutic candidates New York, NY, October 15, 2024 – PRISM
NEW YORK, October 14, 2024 – PRISM MediaWire – JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., is excited to announce a series of
PITTSBURGH, Oct. 09, 2024 – PRISM MediaWire – Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious
London, October 5, 2024 – PRISM MediaWire – We are pleased to share an exclusive interview with Newton Santana, President and Director of BEVAP Bioenergy,
London, October 5, 2024 – PRISM MediaWire – Temos o prazer de compartilhar uma entrevista exclusiva com Newton Santana, Presidente e Diretor da BEVAP Bioenergia,
Londres, October 5, 2024 – PRISM MediaWire – Nos complace compartir una entrevista exclusiva con Newton Santana, Presidente y Director de BEVAP Bioenergía, en anticipación
Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad Laboratories IRVINE, Calif., Oct. 02, 2024 – Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850